Tolerability and Safety of the New Anti-Obesity Medications

Worldwide obesity prevalence has nearly doubled since 1980. Due to numerous co-morbidities, obesity represents a serious health and socioeconomic problem worldwide. Pharmacotherapy should be an integral part of comprehensive obesity management. Drug therapy can assist in weight loss and its maintena...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety 2014-09, Vol.37 (9), p.693-702
Hauptverfasser:	Hainer, Vojtech, Aldhoon-Hainerová, Irena
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Obesity Agents - administration & dosage Anti-Obesity Agents - adverse effects Behavior modification Benzazepines - adverse effects Benzoxazines - adverse effects Biological and medical sciences Bupropion - adverse effects Cardiovascular disease Chemistry, Pharmaceutical Diabetes Drug Safety and Pharmacovigilance Drug-Related Side Effects and Adverse Reactions Fructose - administration & dosage Fructose - adverse effects Fructose - analogs & derivatives Gastrointestinal surgery General and cellular metabolism. Vitamins Glucagon-Like Peptide 1 - adverse effects Glucagon-Like Peptide 1 - analogs & derivatives Growth hormones Humans Hypertension Lifestyles Liraglutide Medical sciences Medicine Medicine & Public Health Metabolic disorders Mortality Naltrexone - adverse effects Obesity Obesity - drug therapy Patient safety Patients Pharmacology. Drug treatments Pharmacology/Toxicology Phentermine - administration & dosage Phentermine - adverse effects Review Article Studies Substance abuse treatment Weight control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!